Risk factors for recurrence of malignant melanoma in patients with negative sentinel lymph node biopsy
2019 · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 4 citations
https://doi.org/10.1111/ddg.13879
O
Oana‐Diana Persa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
367
Citations
7
h-index
7
i10-index
Oana‐Diana Persa is an academic researcher from Technical University of Munich. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cutaneous Melanoma Detection and Management & Renal Transplantation Outcomes and Treatments. The author has an h-index of 7, co-authored 62 publications.
ORCID: 0000-0003-1469-4464Papers by this author
worksElevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage <scp>IV</scp> Melanoma
2025 · Cancer Medicine · 4 citations
https://doi.org/10.1002/cam4.70631
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score
2022 · PLoS ONE · 3 citations
https://doi.org/10.1371/journal.pone.0273478
Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma
2025 · npj Precision Oncology · 2 citations
https://doi.org/10.1038/s41698-025-00997-4
Histo-Miner: Deep learning based tissue features extraction pipeline from H&E whole slide images of cutaneous squamous cell carcinoma
2026 · PLoS Computational Biology · 0 citations
https://doi.org/10.1371/journal.pcbi.1013907
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat